MACOM is trading at $239.33, up +4.18%, with no clear company-specific catalyst identified.

  • MACOM’s latest announcement scheduled fiscal 2026 results for November 5.
  • A Susquehanna analyst assigned a Hold rating with a $300 target; neither item establishes a reason for the rise.
  • The previous session’s sharp decline was attributed to broad semiconductor weakness and AI-spending concerns, but available evidence does not show those conditions explain this morning’s move.